Minnesota Oncology is pleased to announce the association of Madhu Emani, M.D., with the practice of Medical Oncology and Hematology at our Edina Clinic beginning January 2, 2017. {image_1}
“I strive to provide evidence-based high quality care to all my patients,” Dr. Emani says. “I empower my patients with information needed to make meaningful and informed choices while I guide them every step of the way though their journey.”
Dr. Emani received his medical degree from Sri Siddhartha Medical College in Tumkur, India. He completed an internship at St. Martha’s Hospital & Sri Siddhartha Medical College in India and residencies in internal medicine at University of Florida College of Medicine in Jacksonville, Florida and at Manipal University in India. He completed his fellowship in medical oncology at the University of Florida College of Medicine in Jacksonville, Florida.
Dr. Emani is board certified in Medical Oncology and Hematology. His areas of special interest are colorectal cancer, lung cancer, breast cancer and lymphomas. His presented his retrospective clinical study titled “Outcome data for patients with colorectal cancer treated with adjuvant chemotherapy at a single academic institution” at the American Society of Clinical Oncology Annual Meeting in 2014. He has also recently published case studies in the Journal of Oncology Pharmacy Practice and Blood, the journal of the American Society of Hematology.
Dr. Emani recently relocated to Minnesota from Florida where he practiced oncology and hematology at Florida Cancer Affiliates. “My life revolves around my beautiful wife and daughter,” Dr. Emani says. “I enjoy photography and traveling and hope to experience different customs and cultures around the world.”
Appointments with Dr. Emani can be made by calling our Edina Clinic at 952-928-2900.
Share
Categories
Tags
Recent Posts
Understanding Cancer Risks and Screening in the Trans and Nonbinary Community. The World Professional Association of Transgender Health (WPATH) has developed Standards of Care for transgender and gender-diverse (TGD) patients, there are no specific guidelines for cancer screening. In the absence of TGD-specific screening guidelines, cisgender protocols are recommended--this is true where organs remain in place or, in some cases, where there has been gender-confirmation surgery.
Now that you’ve conquered the challenge of cancer treatment, it’s time to consider what’s next for your career and family life. Whether you’re thinking about returning to your previous role or exploring new opportunities, the path forward is yours to choose.
Questions to Ask Your Doctor After Cancer Treatment. Navigating life after cancer treatment can feel like stepping into uncharted territory. As you move forward from treatment to survivorship care, having open and informative conversations with your healthcare team, including your general practitioner and other medical professionals outside of your cancer care team, is crucial.